Approval · Notice of Compliance 3207 · 1998
SAIZEN: Notice of Compliance 3207
Issued May 13, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3207
- Date
- May 13, 1998
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facilities & new strength
- Therapeutic class
- Human growth hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SAIZEN | 02237971 | Marketed |
Medicinal ingredients
- SOMATROPIN 5 MG per VIAL